Exparel 133 MG/10 ML vial 10ML
Ended Awarded
- Contract number
- SPE2DX25F5ZWJ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $10,551
Award facts
- Contract value 100% obligated
- $10,550.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $10,550.54 firm fixed-price delivery order on May 12, 2025, by the Defense Logistics Agency's Medical Supply Chain division for the supply of EXPAREL 133 mg/10 ml vials. The award carries an ultimate completion date of June 3, 2025, and does not utilize a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $499,999,999 through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products supporting military healthcare facilities nationwide.
EXPAREL is a liposomal bupivacaine injectable anesthetic used for prolonged pain relief in surgical and medical settings. As a primary supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group leverages its established position to distribute branded and generic prescription drugs, biologics, and medical consumables directly to Department of Defense healthcare sites. This particular delivery order reflects the ongoing operational needs of the military medical supply system and demonstrates the company's continued role as a critical vendor for Defense Logistics Agency pharmaceutical procurement.
Quick answers
Who was awarded contract SPE2DX25F5ZWJ?
SPE2DX25F5ZWJ was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on May 12, 2025.
How much is contract SPE2DX25F5ZWJ worth?
The government has obligated $10,551 on SPE2DX25F5ZWJ.
Is contract SPE2DX25F5ZWJ an order under another contract?
Yes. SPE2DX25F5ZWJ is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F5ZWJ competed?
The extent of competition for SPE2DX25F5ZWJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award